Table 3.
Clinical outcome of patients with periodontitis after KT
| Variable | Total (n = 303) | Stage I and II (n = 160) | Stage III (n = 89) | Stage IV (n = 54) | p-value |
|---|---|---|---|---|---|
| GFR (mL/min/1.73 m2) | |||||
| 1-Month GFR | 69.82 ± 19.91 | 69.71 ± 20.50 | 70.12 ± 17.73 | 69.62 ± 21.83 | 0.99 |
| 1-Year GFRa | 65.67 ± 16.96 | 64.68 ± 18.50 | 67.19 ± 12.61 | 66.43 ± 18.03 | 0.56 |
| 3-Year GFRb | 67.31 ± 17.71 | 67.07 ± 19.76 | 67.96 ± 13.41 | 67.14 ± 14.55 | 0.95 |
| Rejection | |||||
| AMR | 18 (5.9) | 9 (5.6) | 4 (4.5) | 5 (9.3) | 0.47 |
| ATMR or borderline ATMR | 113 (37.3) | 69 (43.1) | 31 (34.8) | 13 (24.1) | 0.01 |
| Graft loss | 14 (4.6) | 7 (4.4) | 4 (4.5) | 3 (5.6) | 0.75 |
| Infection | |||||
| Bacterial infection | 71 (23.4) | 39 (24.4) | 19 (21.3) | 13 (24.1) | 0.84 |
| CMV viremia | 43 (14.2) | 20 (12.5) | 17 (19.1) | 6 (11.1) | 0.82 |
| BK viremia | 53 (17.5) | 33 (20.6) | 15 (16.9) | 5 (9.3) | 0.06 |
Data are expressed as mean ± standard deviation or number (%).
AMR, acute antibody-mediated rejection; ATMR, acute T cell-mediated rejection; CMV, cytomegalovirus; GFR, glomerular filtration rate; KT, kidney transplantation.
a
A total of 262 patients who followed up for more than 1 year after KT were included.
b
A total of 202 patients who followed up for more than 3 years after KT were included.